Non-steroidal anti-inflammatory drugs (NSAID)

Key figures
Data
Graphics
Comments

PRESCRIBERS
Main prescribers: General practitioners	77.87%
RATE OF USE
Annual consumption (DDD)	124,985,394
Standardised rate of use (per 100,000 insured persons)	1,090,130.62
Average annual consumption per patient (DDD)	47.98
% Insured persons concerned	22.72%
Approximate % DDD issued outside the insurance	27.23%
% Patients with more than 3 times the average consumption	5.20%
POPULATION
Median age	56 years
Max/min ratio of the median age (by district)	1.19
Percentage of women	57.03%
Ratio Preferential scheme/General scheme	1.37
CONSUMPTION TRENDS (DDD)
Trend 2011-2021	-2.74%
Trend 2011-2019	-1.94%
Trend 2019-2021	-5.86%
GEOGRAPHICAL VARIATIONS
Coefficient of variation 2011-2013	9.37
Coefficient of variation 2019-2021	18.22
Max/min ratio of consumption (DDD per 100,000 insured persons, by region)	1.33
Max/min ratio of consumption ( DDD per 100,000 insured persons, by district)	1.96
DIRECT EXPENDITURE
Annual expenditure charged to the insurance	34,914,509€
Average annual expenditure per insured person	3.05 €
Average patient share (under insurance)	14.25%
Max/min ratio of expenditure per insured person (by region)	1.30
Max/min ratio of expenditure per insured person (by disctrict)	1.93
% “Low-cost” medication	82.74%

On this table, when a statistical test has been performed, the data showing a significant difference is displayed on an yellow background, otherwise on a grey background.

+ - ATC codes selected for analysis Click to collapse

CODES	LABEL	LABEL ATC-5
M01AB01	INDOMETACINE	DERIVES DE L'ACIDE ACETIQUE ET SUBSTANCES APPARENTEES
M01AB05	DICLOFENAC	DERIVES DE L'ACIDE ACETIQUE ET SUBSTANCES APPARENTEES
M01AB15	KETOROLAC	DERIVES DE L'ACIDE ACETIQUE ET SUBSTANCES APPARENTEES
M01AB16	ACECLOFENAC	DERIVES DE L'ACIDE ACETIQUE ET SUBSTANCES APPARENTEES
M01AB55	DICLOFENAC, ASSOCIATIONS	DERIVES DE L'ACIDE ACETIQUE ET SUBSTANCES APPARENTEES
M01AC01	PIROXICAM	OXICAMS
M01AC02	TENOXICAM	OXICAMS
M01AC06	MELOXICAM	OXICAMS
M01AE01	IBUPROFENE	DERIVES DE L'ACIDE PROPIONIQUE
M01AE02	NAPROXENE	DERIVES DE L'ACIDE PROPIONIQUE
M01AE03	KETOPROFENE	DERIVES DE L'ACIDE PROPIONIQUE
M01AE52	NAPROXENE ET ESOMEPRAZOLE	DERIVES DE L'ACIDE PROPIONIQUE
M01AH01	CELECOXIB	COXIBS
M01AH05	ETORICOXIB	COXIBS
M01AX01	NABUMETONE	AUTRES ANTI-INFLAMMATOIRES / ANTIRHUMATISMAUX NON STEROIDIENS

The labels on a blue background are the medicines that exist under the status "low cost".
The codes mentioned above can be used in rates and expenses, or only in expenses. We invite you to consult the full report for more information.

Click here to see the graph illustrating the evolution of the breakdown by volume of ATC codes used for the rates.